Cardiovascular Imaging
MedTrace Pharma A/S focuses on coronary artery disease detection through advanced myocardial perfusion imaging and positron emission tomography approaches used to assess blood flow in the heart.
- Coronary artery disease
- Myocardial perfusion imaging
- Positron emission tomography
The research activity centers on improving diagnostic evaluation of cardiac perfusion under both stress and resting conditions.
Non-Invasive Diagnosis
The sponsor’s trial portfolio includes work on non-invasive methods for identifying ischemic heart disease, with emphasis on imaging-based assessment of coronary circulation.
- Ischemic heart disease
- Coronary circulation
- Diagnostic imaging
Interest extends to defining the diagnostic value of imaging tools used in place of invasive evaluation.
Coronary Function Assessment
Research activity includes evaluation of coronary physiology using reference standards such as fractional flow reserve and instantaneous wave-free ratio in the context of suspected coronary disease.
- Fractional flow reserve
- Instantaneous wave-free ratio
- Coronary physiology
This area reflects a focus on linking imaging findings with functional measures of coronary narrowing.
Computed Tomography Angiography
MedTrace Pharma A/S also engages with coronary computed tomography angiography as part of the diagnostic pathway for evaluating patients with suspected coronary artery disease.
- Coronary computed tomography angiography
- Invasive coronary angiogram
- Cardiac diagnostics
These interests align with comparative assessment of anatomical and functional methods in cardiovascular diagnosis.
Stress and Rest Imaging
The sponsor’s clinical research includes pharmacological stress and resting perfusion imaging to support evaluation of coronary blood supply under different physiological conditions.
- Pharmacological stress
- Resting perfusion imaging
- Cardiac perfusion
Attention is directed toward imaging performance in settings relevant to routine cardiovascular assessment.
